Skip to main content
    V

    Virax Biolabs Group Limited Ordinary Shares (VRAX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.65
    -0.09 (-5.07%)

    Market Cap: $2.39M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Sep 26
    Reported Oct 1
    		$N/A$-1.75N/ABeat-
    Jun 26
    Reported Jul 1
    		$N/A$-1.75N/ABeat-
    Mar 26
    Reported Mar 31
    		$N/A$-1.75N/ABeat-
    Dec 25
    Reported Dec 31
    		$N/A$-2.50N/ABeat-
    Sep 25
    Reported Dec 2
    		$-0.49$0.00N/AMiss-1533.3%
    Jun 25
    Reported Jul 2
    		$-0.76$0.00N/AMiss-
    Mar 25
    Reported Mar 31
    		$N/A$-8.25N/ABeat-
    Sep 24
    Reported Nov 19
    		$-0.89$0.00N/AMiss-
    Jun 22
    Reported Aug 12
    		$-0.03$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.05xFCF Yield-1969.42%
    Profitability
    Profit Margin0.00%Operating Margin-35265.00%
    ROE-78.60%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio9.97xQuick Ratio9.90x
    Trading Statistics
    Beta1.39Avg Volume190.88K
    52-Week High$21.7552-Week Low$1.61

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.01
    SMA 20$2.20
    SMA 50$2.57
    SMA 200$4.37
    EMA 10$1.96
    EMA 20$2.15
    EMA 50$2.56
    EMA 200$5.49

    MACD

    Line: -0.24Signal: -0.20Hist: -0.04

    ADX

    ADX: 17.5+DI: 26.4-DI: 26.0

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down100.0
    PSAR$3.00

    Bollinger Bands

    Upper Band$2.75
    Lower Band$1.66
    %B Position4978%(Upper)
    Band Width-0.00

    RSI (14-Day)

    Oversold
    28.8

    Momentum Oscillators

    Stoch %K2.6
    Stoch %D4.0
    Williams %R-97.7
    ROC (10d)-24.5%
    Momentum-0.53
    CCI (20d)-156.1
    MFI (14d)78.9

    Volatility Measures

    ATR (14d)$0.28(16.9%)
    StdDev (20d)0.27
    Hist Vol90.3%(High)

    Volume Flow

    VWAP$1.68
    OBV1.9B
    AD Line290.9B
    CMF (20d)-0.408

    Volume Metrics

    Avg Vol (20d)207.6K
    Vol Ratio0.2x(Low)
    VWMA (20d)$2.31

    Pivot Points

    R3$1.97
    R2$1.91
    R1$1.83
    Pivot Point$1.77
    S1$1.69
    S2$1.63
    S3$1.55

    Advanced Oscillators

    TSI-30.47
    Ultimate Osc39.4
    KST-240.57

    Financial Data

    QuarterJun 2026Sep 2025Jun 2025Sep 2024Jun 2024Sep 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021
    Total Revenue$12,423$1,608$1,378$4,953$79,919$76,500$2,801$2,801$5,760$-92,865$-92,865$30,955
    Cost of Revenue$4,733$217,022$47,971$11,427$39,847$65,982$4,284$4,284$5,642$99,940N/A$33,313
    Gross Profit$7,690$-215,414$-46,593$-6,474$40,072$10,518$-1,483$-1,483$118$-192,805N/AN/A
    Operating Expenses$6.41M$2.37M$3.24M$2.87M$3.83M$2.72M$4.29M$4.29M$1.44M$1.17M$436,686$173,143
    R&D$3.74M$1.38M$1.05M$726,412$1.15M$409,295$300,487$300,487$96,622$325,646$0$30,055
    SG&A$2.67M$0$2.18M$2.15M$2.25M$2.27M$3.96M$4.02M$1.29M$831,536$324,984$128,720
    Operating Income$-6,399,730$-2,585,475$-3,284,006$-2,878,891$-3,790,250$-2,706,220$-4,292,190$-4,292,190$-1,440,580$-1,166,940N/AN/A
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$61,772$30,991$32,588$25,591$16,764$10,114$5,860$5,860$9,608$1,294$0$0
    Income Before Tax$-5,932,424$-2,616,867$-3,310,668$-2,893,225$-3,824,916$-2,914,204$-4,003,977$-4,003,977$-1,453,786$-1,174,830$0$0
    Income Tax Expense$-900,240$-273,594$0$-136,661$-1,031$-4,551$-4,282,280$-4,282,280$-1,450,751$16,647$0$0
    Net Income$-5,023,750$-2,338,771$-3,304,820$-2,756,427$-3,823,885$-2,909,652$-4,013,883$-4,013,883$-1,443,611$-1,156,411$-427,395N/A
    EBITDA$-5,648,335$-2,369,174$-3,098,810$-2,720,700$-3,722,775$-2,688,500$294,070$294,070$-3,600N/AN/AN/A
    EBIT$-5,870,652$-2,585,875$-3,284,006$-2,878,891$-3,808,155$-2,706,219$-3,998,115$-3,998,115$-1,444,176N/AN/AN/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about VRAX

    VRAX Valuation and Fair Value

    P/FCF
    -0.1x
    P/B
    0.1x
    See GNG's fair value

    VRAX Profitability: Margins, ROIC and FCF

    Operating margin
    -35265.0%
    Net margin
    0.0%
    ROE
    -78.6%
    FCF margin
    -104024.4%
    FCF yield
    -1969.4%

    VRAX Competitors

    CompanyTicker
    Flora Growth CorpFLGC
    Scisparc LtdSPRC
    Elevai Labs, Inc. Common StockELAB
    Nuwellis IncNUWE
    GeoVax Labs IncGOVX
    Im Cannabis CorpIMCC
    Matinas BioPharma Holdings IncMTNB
    Qualigen Therapeutics IncQLGN

    Sector: Healthcare

    VRAX Bull Case vs Bear Case

    Bull case

    • VRAX grew quarterly revenue 685.0% year over year.

    VRAX Earnings: Beat Rate and Next Report

    Beat rate
    0 of 4 quarters (0.0%)

    Frequently Asked Questions About VRAX

    Does VRAX pay dividends?

    Virax Biolabs Group Limited Ordinary Shares (VRAX) does not currently pay a regular dividend.

    What is VRAX's market cap?

    Virax Biolabs Group Limited Ordinary Shares (VRAX) has a market capitalization of $2.39M with a current stock price of $1.65.

    Related stocks

    Sector: Healthcare

    All stocks starting with V

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In